- JNJ -0.81%
Search results
- 145.62Add to watchlist-1.20 (-0.81%)As of Tue. Apr 30, 2024 12:14 PM EDT · Nasdaq Real Time Price (USD) · Market open
- Open146.88High146.88Low145.35
- Mkt Cap350.92BP/E (TTM)19.60Div & Yield4.96 & 3.38%
- Prev. Close146.8252 Wk. Low143.1352 Wk. High175.97
What analysts are sayingTop storiesJohnson & Johnson's (NYSE:JNJ) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?Yahoo Finance · 1 day ago- JNJ -0.81%
The Art of Valuation: Discovering Johnson & Johnson's Intrinsic ValueYahoo Finance · 1 day ago- JNJ -0.81%
Johnson & Johnson's (NYSE:JNJ) Dividend Will Be Increased To $1.24Yahoo Finance · 5 days agoRelated stocks
Find the latest Johnson & Johnson (JNJ) stock quote, history, news and other vital information to help you with your stock trading and investing.
Sep 27, 2023 · Discover J&J. At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated and cured, treatments are smarter and less invasive and solutions are personal.
Apr 16, 2024 · You should view the News section and the most recent SEC Filings in the Investor sectionin order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
CORONAVIRUS. The Johnson & Johnson vaccine is based on the virus’s genetic instructions for building the spike protein. But unlike the Pfizer-BioNTech and Moderna vaccines, which store the ...
Mar 5, 2021 · The third COVID-19 vaccine authorized for use in the U.S. requires one shot instead of two, and works a slightly different way from the others. Here's what we know about its safety and effectiveness.
Feb 27, 2021 · F.D.A. Clears Johnson & Johnson’s Shot, the Third Vaccine for U.S. The authorization of a third Covid-19 vaccine will bring millions more doses within days. But health officials worry that some ...
Apr 13, 2021 · As of April 12, more than 6.8 million doses of the Johnson & Johnson (Janssen) vaccine have been administered in the U.S. CDC and FDA are reviewing data involving six reported U.S. cases of a rare ...